Enfusion Inc
NYSE:ENFN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.78
11.03
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Enfusion Inc
Enfusion Inc
Research & Development
Enfusion Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Enfusion Inc
NYSE:ENFN
|
Research & Development
-$19.9m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Salesforce Inc
NYSE:CRM
|
Research & Development
-$5.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-22%
|
|
|
|
Palantir Technologies Inc
NYSE:PLTR
|
Research & Development
-$404.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Applovin Corp
NASDAQ:APP
|
Research & Development
-$592.4m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-105%
|
CAGR 10-Years
N/A
|
|
|
Intuit Inc
NASDAQ:INTU
|
Research & Development
-$2.8B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-14%
|
|
|
Adobe Inc
NASDAQ:ADBE
|
Research & Development
-$3.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-17%
|
|
Enfusion Inc
Glance View
Enfusion Inc. emerges as a notable player in the financial technology landscape, focusing on streamlining operations for investment managers through its cloud-native platform. Founded in Chicago, Enfusion began its journey to address the complexities faced by hedge funds and asset managers. By offering a cohesive suite of solutions, including portfolio management, order management, and accounting systems, Enfusion has carved a niche for itself. These integrated services enable clients to manage their entire investment lifecycle from a singular platform, eliminating the cumbersome need for multiple disconnected systems. This efficiency not only bolsters operational effectiveness but also offers significant cost savings, making Enfusion an attractive proposition for financial firms looking to modernize their back-office functions. The company generates revenue through a scalable, subscription-based model. Clients pay for access to Enfusion's robust software platform and the array of offerings it includes. This model provides Enfusion with a steady, predictable income stream, while also allowing clients the flexibility to tailor solutions according to their specific needs and scale, as necessary, without incurring significant upfront costs. Adding to its appeal, Enfusion provides comprehensive customer support and continuous software updates, ensuring that clients always work with the most current tools. By prioritizing innovation and client-centric services, Enfusion not only retains its existing customers but also continually attracts new ones in an industry that values both technological advancement and operational efficiency.
See Also
What is Enfusion Inc's Research & Development?
Research & Development
-19.9m
USD
Based on the financial report for Dec 31, 2023, Enfusion Inc's Research & Development amounts to -19.9m USD.
What is Enfusion Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-47%
Over the last year, the Research & Development growth was -16%. The average annual Research & Development growth rates for Enfusion Inc have been -47% over the past three years .
You don't have any saved screeners yet
